Reishi (Ganoderma lucidum) is a functional mushroom containing a wide range of bioactive compounds. Among the most extensively studied are polysaccharides, triterpenoids and ganoderic acids.

One area of growing scientific interest is the potential relationship between Reishi and cholesterol, lipid metabolism, oxidative stress and blood vessel function.

It is important to distinguish potential biological mechanisms from clinically proven effects. At present, there is insufficient clinical evidence to claim that Reishi lowers high cholesterol or treats atherosclerosis. However, individual compounds found in Ganoderma lucidum are being investigated in relation to mechanisms associated with lipid metabolism, LDL oxidation and vascular function.

What is cholesterol and why is LDL important?

Cholesterol itself is not a harmful substance. The human body needs cholesterol to build cell membranes, produce steroid hormones and perform many other essential biological functions.

Problems may arise when LDL cholesterol, often referred to as “bad cholesterol”, remains elevated over a prolonged period.

LDL particles can enter the walls of blood vessels and participate in the development of atherosclerotic processes. Modification and oxidation of these lipoproteins are particularly important because oxidative stress is associated with inflammatory processes and impaired endothelial function.

For this reason, modern cardiovascular research focuses not only on the amount of cholesterol circulating in the blood but also on what happens within the blood vessel wall itself.

Reishi, LDL and oxidative stress

One reason Ganoderma lucidum attracts scientific attention is its wide spectrum of biologically active compounds.

In experimental studies, compounds found in the Reishi mushroom have been investigated in relation to antioxidant mechanisms and oxidative stress.

This is particularly interesting in the context of LDL cholesterol.

When LDL particles undergo oxidative modification, they may participate more actively in processes associated with endothelial dysfunction and the development of atherosclerotic changes.

The potential interaction between Reishi compounds and oxidative-stress-related mechanisms is therefore an interesting area of research in the context of cholesterol and blood vessel health.

However, this does not mean that taking Reishi extract prevents atherosclerosis or reverses damage to blood vessels.

Reishi and the vascular endothelium

The inner surface of blood vessels is covered by a thin layer of cells known as the endothelium.

The endothelium plays an active role in regulating:

• dilation and constriction of blood vessels;
• blood flow;
• interactions between blood cells and vessel walls;
• inflammatory processes;
• vascular tone.

Oxidative stress, smoking, high blood pressure, impaired glucose metabolism and elevated LDL cholesterol can negatively affect endothelial function.

This is why the bioactive compounds found in Reishi mushroom extract are scientifically interesting not only in relation to cholesterol levels themselves but also in the broader context of interactions between lipids, oxidative stress and vascular function.

Can Reishi reduce the harmful effects of cholesterol on blood vessels?

This question requires careful wording.

Research into individual Ganoderma lucidum compounds allows scientists to investigate potential mechanisms related to antioxidant activity, inflammatory signalling pathways, lipid metabolism and vascular function.

Theoretically, these mechanisms may be relevant to understanding the processes through which elevated LDL can negatively affect blood vessel walls.

However, this does not demonstrate that Reishi extract protects blood vessels from high cholesterol or prevents cardiovascular disease.

Much stronger clinical evidence in humans would be required to support such claims.

Reishi and vascular tone

The condition of our blood vessels is not determined by cholesterol levels alone.

The ability of blood vessel walls to relax and contract normally is also important. The endothelium, nitric oxide and numerous cellular signalling mechanisms participate in these processes.

Some Ganoderma lucidum triterpenoids have been investigated in the context of biological mechanisms related to vascular function.

It is therefore more scientifically accurate to say that Ganoderma lucidum bioactive compounds are being investigated in relation to vascular tone regulation and endothelial function, rather than claiming that “Reishi prevents blood vessel spasms”.

Reishi and cholesterol levels – what do human studies show?

This is where the evidence becomes considerably less clear than the results of laboratory and animal studies.

A Cochrane systematic review evaluated clinical research on Ganoderma lucidum in relation to cardiovascular risk factors, including blood lipids, glucose and blood pressure.

The authors found insufficient evidence to support the use of Ganoderma lucidum for the treatment of cardiovascular risk factors.

This distinction is important because results observed in laboratory experiments or animal models cannot automatically be translated into a clinical effect in humans.

Therefore, the statement “Reishi lowers cholesterol” would currently be too strong.

A more accurate statement is:

Ganoderma lucidum and its bioactive compounds are being studied in relation to lipid metabolism, oxidative stress and vascular function, but there is currently insufficient convincing clinical evidence that Reishi lowers elevated cholesterol in humans.

Which Reishi compounds are of greatest scientific interest?

Polysaccharides

Reishi polysaccharides, including various beta-glucan-related structures, are among the most extensively studied compounds in Ganoderma lucidum.

They are investigated in relation to immune function, antioxidant mechanisms and cellular signalling pathways.

Triterpenoids

Reishi triterpenoids are a characteristic group of compounds found in Ganoderma lucidum. They also contribute to the distinctive bitter taste associated with concentrated Reishi extracts.

These compounds are being investigated in relation to numerous biological mechanisms, including inflammatory signalling pathways and metabolic processes.

Ganoderic acids

Ganoderic acids are characteristic triterpenoid compounds found in Ganoderma lucidum.

For this reason, when comparing different Reishi supplements and Reishi extracts, it is useful to consider not only the amount of mushroom powder or extract but also the standardised concentration of bioactive compounds.

Reishi Premium – standardised Ganoderma lucidum extract

ReishiPremium.com focuses on a standardised Ganoderma lucidum fruiting body extract with defined levels of key bioactive compounds.

This makes it possible to evaluate a Reishi extract not simply by the number of grams or milligrams in a package, but also by the actual concentration of its key bioactive constituents.

Reishi Premium extract contains:

≥30.81% polysaccharides
≥6.42% triterpenoids
≥3.05% ganoderic acids

These are among the principal groups of Ganoderma lucidum compounds investigated in scientific research.

When choosing a Reishi mushroom extract, it is therefore worth considering the part of the mushroom used, the extraction method and the laboratory-determined concentration of bioactive compounds.

This is particularly important because Reishi mushroom powder and a concentrated Reishi extract are not the same product. Their concentrations of bioactive compounds can differ substantially.

More information about Reishi Premium extract, its composition, use and price can be found at ReishiPremium.com.

Reishi and cholesterol – what can we conclude?

Scientific interest in Reishi and cholesterol extends far beyond the simple question of whether the mushroom directly lowers LDL cholesterol.

Research examines a broader chain of interconnected processes:

LDL cholesterol → oxidative stress → endothelium → blood vessel wall → inflammatory signalling → cardiovascular physiology.

Bioactive compounds found in Ganoderma lucidum, particularly polysaccharides, triterpenoids and ganoderic acids, are being investigated within different parts of these biological processes.

It is therefore more accurate to view the Reishi mushroom not as a treatment for high cholesterol, but as a source of bioactive compounds whose properties and biological mechanisms continue to be actively investigated.

With a standardised Reishi extract, the concentrations of major bioactive compounds are known, providing considerably more information when comparing Ganoderma lucidum products than simply looking at the total amount of mushroom powder or extract.

More information about standardised Ganoderma lucidum fruiting body extract is available at ReishiPremium.com.

Important information: This article is an informational review of scientific literature and is not medical advice. The studies discussed do not demonstrate that Reishi or any specific Reishi supplement prevents, treats or cures high cholesterol, atherosclerosis or cardiovascular disease.

Scientific references

Klupp NL, Chang D, Hawke F, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database of Systematic Reviews, 2015.

Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom. Herbal Medicine: Biomolecular and Clinical Aspects, 2nd edition, 2011.